Adverse effect | Heart transplant recipients (n = 78) | Non-transplant patients (n = 156) | p value |
---|---|---|---|
Death, n (%) | 0 | 0 | N/A |
Asystole, n (%) | 0 | 0 | N/A |
Sinus pause or arrest, n (%) | 0 | 0 | N/A |
High-grade atrioventricular block, n (%) | 0 | 0 | N/A |
Ventricular tachycardia or ventricular fibrillation, n (%) | 0 | 0 | N/A |
Atrial fibrillation, n (%) | 0 | 0 | N/A |
Chest pain requiring sublingual nitroglycerin, n (%) | 1 (1) | 0 | 0.33 |
Myocardial infarction, n (%) | 0 | 0 | N/A |
Symptomatic hypotension, n (%) | 1 (1) | 1 (0.6) | 0.65 |
Dyspnea, n (%) | 6 (7) | 9 (6) | 0.58 |
Nausea, n (%) | 6 (7) | 3 (2) | 0.08 |
Headache, n (%) | 2 (3) | 0 | 0.11 |
Allergic reaction (rash, hives, etc.), n (%) | 0 | 0 | N/A |
Contrast extravasation, n (%) | 0 | 2 (1) | 0.55 |
Thrombophlebitis, n (%) | 0 | 0 | N/A |
Hospitalization, n (%) | 0 | 0 | N/A |